|Bid||56.30 x 100|
|Ask||61.68 x 200|
|Day's Range||59.57 - 60.33|
|52 Week Range||57.80 - 80.02|
|PE Ratio (TTM)||10.83|
|Earnings Date||Jul 24, 2017 - Jul 28, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||65.88|
More competition could help overcome the suspicion over drug prices that plagues the would-be business partners' dealings.
These 5 undervalued stocks are healthcare companies worth a second look.
New Research Reports for Oracle, Chubb, AstraZeneca & Others